Evidence map›Paper›PMID 36834671›Full record

ArticleInternational journal of molecular sciences2023

Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association.

Barbara Kneis, Stefan Wirtz, Klaus Weber, Axel Denz, Matthias Gittler, Carol Geppert, Maximilian Brunner, Christian Krautz, Alexander Reinhard Siebenhüner, Robert Schierwagen and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Barbara KneisDepartment of Nephrology, University Hospital Erlangen, 91054 Erlangen, Germany.
Stefan WirtzDepartment of Internal Medicine I, University Hospital Erlangen, 91054 Erlangen, Germany.
Klaus WeberDepartment of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.
Axel DenzDepartment of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.ORCID 0000-0002-3523-198X
Matthias GittlerDepartment of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.
Carol GeppertInstitute of Pathology, University Hospital Erlangen, 91054 Erlangen, Germany.
Maximilian BrunnerDepartment of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.
Christian KrautzDepartment of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.ORCID 0000-0002-2537-5824
Alexander Reinhard SiebenhünerDepartment of Gastroenterology and Hepatology, University Hospital Zurich and University Zurich, 8091 Zürich, Switzerland.ORCID 0000-0002-5404-2383
Robert SchierwagenDepartment of Internal Medicine B, University Hospital Münster, 48149 Münster, Germany.
Olaf TycDepartment of Internal Medicine I, University Clinic Frankfurt, 60590 Frankfurt, Germany.ORCID 0000-0001-9949-0975
Abbas AgaimyInstitute of Pathology, University Hospital Erlangen, 91054 Erlangen, Germany.ORCID 0000-0002-0445-8161
Robert GrützmannDepartment of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.
Jonel TrebickaDepartment of Internal Medicine B, University Hospital Münster, 48149 Münster, Germany.ORCID 0000-0002-7028-3881
Stephan KerstingDepartment of Surgery, University Hospital Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-2124-3103
Melanie LangheinrichDepartment of Surgery, University Hospital Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-0120-9135
Universitätsklinikum Erlangen · DEUniversitätsmedizin Greifswald · DEUniversity Hospital Münster · DEGoethe University Frankfurt · DEUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current era of precision oncology, it is widely acknowledged that CRC is a heterogeneous disease entity. Tumor location (right- or left-sided colon cancer or rectal cancer) is a crucial factor in determining disease progression as well as prognosis and influences disease management. In the last decade, numerous works have reported that the microbiome is an important element of CRC carcinogenesis, progression and therapy response. Owing to the heterogeneous nature of microbiomes, the findings of these studies were inconsistent. The majority of the studies combined colon cancer (CC) and rectal cancer (RC) samples as CRC for analysis. Furthermore, the small intestine, as the major site for immune surveillance in the gut, is understudied compared to the colon. Thus, the CRC heterogeneity puzzle is far from being solved, and more research is necessary for prospective trials that separately investigate CC and RC. Our prospective study aimed to map the colon cancer landscape using 16S rRNA amplicon sequencing in biopsy samples from the terminal ileum, healthy colon tissue, healthy rectal tissue and tumor tissue as well as in preoperative and postoperative stool samples of 41 patients. While fecal samples provide a good approximation of the average gut microbiome composition, mucosal biopsies allow for detecting subtle variations in local microbial communities. In particular, the small bowel microbiome has remained poorly characterized, mainly because of sampling difficulties. Our analysis revealed the following: (i) right- and left-sided colon cancers harbor distinct and diverse microbiomes, (ii) the tumor microbiome leads to a more consistent cancer-defined microbiome between locations and reveals a tumor microbiome-ileal microbiome association, (iii) the stool only partly reflects the microbiome landscape in patients with CC, and (iv) mechanical bowel preparation and perioperative antibiotics together with surgery result in major changes in the stool microbiome, characterized by a significant increase in the abundance of potentially pathogenic bacteria, such as

Indexed as

Colonic NeoplasmsGastrointestinal MicrobiomeRectal NeoplasmsColonHumansIleumPrecision MedicineProspective StudiesRNA, Ribosomal, 16SRNA, Ribosomal, 16Scolon cancergut microbiomeleft-sided colon cancermicrobiomeright-sided colon cancertumor microbiome

Identifiers

PMID36834671
PMCPMC9963782
OpenAlexW4319600915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.